Elevance Health, Inc.
ELV
$448.74
-$3.95-0.87%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 144.68B | 143.03B | 141.37B | 137.82B | 134.71B |
| Total Other Revenue | 26.66B | 25.60B | 24.34B | 22.85B | 21.89B |
| Total Revenue | 171.34B | 168.63B | 165.72B | 160.68B | 156.60B |
| Cost of Revenue | 124.33B | 123.19B | 122.01B | 119.20B | 116.64B |
| Gross Profit | 47.01B | 45.44B | 43.71B | 41.48B | 39.96B |
| SG&A Expenses | 35.51B | 34.99B | 33.55B | 31.75B | 30.70B |
| Depreciation & Amortization | 885.00M | 915.00M | 928.00M | 873.00M | 767.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.72B | 159.09B | 156.49B | 151.82B | 148.11B |
| Operating Income | 10.62B | 9.53B | 9.23B | 8.86B | 8.49B |
| Income Before Tax | 7.72B | 7.76B | 8.23B | 7.91B | 7.60B |
| Income Tax Expenses | 1.72B | 1.72B | 1.90B | 1.80B | 1.71B |
| Earnings from Continuing Operations | 5.99K | 6.04K | 6.34K | 6.11K | 5.89K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.00M | -41.00M | -25.00M | -19.00M | 6.00M |
| Net Income | 5.99B | 6.00B | 6.31B | 6.09B | 5.89B |
| EBIT | 10.62B | 9.53B | 9.23B | 8.86B | 8.49B |
| EBITDA | 12.36B | 11.33B | 11.05B | 10.64B | 10.17B |
| EPS Basic | 25.31 | 25.27 | 26.48 | 25.45 | 24.49 |
| Normalized Basic EPS | 25.34 | 22.31 | 21.59 | 20.68 | 19.86 |
| EPS Diluted | 25.17 | 25.13 | 26.30 | 25.24 | 24.26 |
| Normalized Diluted EPS | 25.21 | 22.18 | 21.44 | 20.50 | 19.67 |
| Average Basic Shares Outstanding | 945.20M | 950.60M | 954.90M | 959.00M | 962.90M |
| Average Diluted Shares Outstanding | 949.80M | 955.20M | 960.90M | 966.50M | 971.20M |
| Dividend Per Share | 5.92 | 5.72 | 5.52 | 5.32 | 5.12 |
| Payout Ratio | 23.30% | 22.58% | 20.79% | 20.86% | 20.85% |
